Pyroptosis: A Novel Intervention Target in the Progression of Osteoarthritis

References

• Monack DM, Raupach B, Hromockyj AE, Falkow S. Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc Natl Acad Sci USA. 1996;93(18):9833–9838. doi:10.1073/pnas.93.18.9833
   PubMed Web of Science ®Google Scholar
• Zychlinsky A, Prevost MC, Sansonetti PJ. Shigella flexneri induces apoptosis in infected macrophages. Nature. 1992;358(6382):167–169. doi:10.1038/358167a0
   PubMed Web of Science ®Google Scholar
• Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A. The salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci USA. 1999;96(5):2396–2401. doi:10.1073/pnas.96.5.2396
   PubMed Web of Science ®Google Scholar
• Cookson BT, Brennan MA. Pro-inflammatory programmed cell death. Trends Microbiol. 2001;9(3):113–114. doi:10.1016/s0966-842x(00)01936-3
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018;25(3):486–541. doi:10.1038/s41418-017-0012-4
   PubMed Web of Science ®Google Scholar
• Voet S, Srinivasan S, Lamkanfi M, van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med. 2019;11(6). doi:10.15252/emmm.201810248
   PubMed Web of Science ®Google Scholar
• Ji N, Qi Z, Wang Y, et al. Pyroptosis: a new regulating mechanism in cardiovascular disease. J Inflamm Res. 2021;14:2647–2666. doi:10.2147/jir.S308177
   PubMed Web of Science ®Google Scholar
• Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646–656.
   PubMed Web of Science ®Google Scholar
• Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Curr Opin Rheumatol. 2018;30(2):160–167. doi:10.1097/bor.0000000000000479
   PubMed Web of Science ®Google Scholar
• Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin North Am. 2020;104(2):293–311. doi:10.1016/j.mcna.2019.10.007
   PubMed Web of Science ®Google Scholar
• Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42(4):245–254. doi:10.1016/j.tibs.2016.10.004
   PubMed Web of Science ®Google Scholar
• Van Opdenbosch N, Lamkanfi M. Caspases in cell death, inflammation, and disease. Immunity. 2019;50(6):1352–1364. doi:10.1016/j.immuni.2019.05.020
   PubMed Web of Science ®Google Scholar
• He WT, Wan H, Hu L, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 2015;25(12):1285–1298. doi:10.1038/cr.2015.139
   PubMed Web of Science ®Google Scholar
• Broz P, Pelegrín P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020;20(3):143–157. doi:10.1038/s41577-019-0228-2
   PubMed Web of Science ®Google Scholar
• Ding J, Wang K, Liu W, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535(7610):111–116. doi:10.1038/nature18590
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang Z, Ruan J, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535(7610):153–158. doi:10.1038/nature18629
   PubMed Web of Science ®Google Scholar
• Aglietti RA, Dueber EC. Recent insights into the molecular mechanisms underlying pyroptosis and gasdermin family functions. Trends Immunol. 2017;38(4):261–271. doi:10.1016/j.it.2017.01.003
   PubMed Web of Science ®Google Scholar
• Sandstrom A, Mitchell PS, Goers L, Mu EW, Lesser CF, Vance RE. Functional degradation: a mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes. Science. 2019;364(6435). doi:10.1126/science.aau1330
   PubMed Web of Science ®Google Scholar
• Ghimire L, Paudel S, Jin L, Jeyaseelan S. The NLRP6 inflammasome in health and disease. Mucosal Immunol. 2020;13(3):388–398. doi:10.1038/s41385-020-0256-z
   PubMed Web of Science ®Google Scholar
• Mullins B, Chen J. NLRP9 in innate immunity and inflammation. Immunology. 2021;162(3):262–267. doi:10.1111/imm.13290
   PubMed Web of Science ®Google Scholar
• He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41(12):1012–1021. doi:10.1016/j.tibs.2016.09.002
   PubMed Web of Science ®Google Scholar
• Sundaram B, Kanneganti TD. Advances in understanding activation and function of the NLRC4 inflammasome. Int J Mol Sci. 2021;22(3):1048. doi:10.3390/ijms22031048
   PubMed Web of Science ®Google Scholar
• Hornung V, Ablasser A, Charrel-Dennis M, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 2009;458(7237):514–518. doi:10.1038/nature07725
   PubMed Web of Science ®Google Scholar
• Schnappauf O, Chae JJ, Kastner DL, Aksentijevich I. The pyrin inflammasome in health and disease. Front Immunol. 2019;10:1745. doi:10.3389/fimmu.2019.01745
   PubMed Web of Science ®Google Scholar
• Kayagaki N, Warming S, Lamkanfi M, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479(7371):117–121. doi:10.1038/nature10558
   PubMed Web of Science ®Google Scholar
• Shi J, Zhao Y, Wang Y, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514(7521):187–192. doi:10.1038/nature13683
   PubMed Web of Science ®Google Scholar
• Viganò E, Diamond CE, Spreafico R, Balachander A, Sobota RM, Mortellaro A. Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes. Nat Commun. 2015;6:8761. doi:10.1038/ncomms9761
   PubMed Web of Science ®Google Scholar
• Yang J, Liu Z, Wang C, et al. Mechanism of gasdermin D recognition by inflammatory caspases and their inhibition by a gasdermin D-derived peptide inhibitor. Proc Natl Acad Sci USA. 2018;115(26):6792–6797. doi:10.1073/pnas.1800562115
   PubMed Web of Science ®Google Scholar
• Aglietti RA, Estevez A, Gupta A, et al. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci USA. 2016;113(28):7858–7863. doi:10.1073/pnas.1607769113
   PubMed Web of Science ®Google Scholar
• Yang D, He Y, Muñoz-Planillo R, Liu Q, Núñez G. Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity. 2015;43(5):923–932. doi:10.1016/j.immuni.2015.10.009
   PubMed Web of Science ®Google Scholar
• Burgener SS, Schroder K. Neutrophil extracellular traps in host defense. Cold Spring Harb Perspect Biol. 2020;12(7):a037028. doi:10.1101/cshperspect.a037028
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao W, Shi X, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99–103. doi:10.1038/nature22393
   PubMed Web of Science ®Google Scholar
• Newton K, Wickliffe KE, Maltzman A, et al. Activity of caspase-8 determines plasticity between cell death pathways. Nature. 2019;575(7784):679–682. doi:10.1038/s41586-019-1752-8
   PubMed Web of Science ®Google Scholar
• Zhou Z, He H, Wang K, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020;368(6494). doi:10.1126/science.aaz7548
   Web of Science ®Google Scholar
• Liu Y, Fang Y, Chen X, et al. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Sci Immunol. 2020;5(43). doi:10.1126/sciimmunol.aax7969
   Web of Science ®Google Scholar
• Safiri S, Kolahi AA, Smith E, et al. Global, regional and national burden of osteoarthritis 1990–2017: a systematic analysis of the global burden of disease study 2017. Ann Rheum Dis. 2020;79(6):819–828. doi:10.1136/annrheumdis-2019-216515
   PubMed Web of Science ®Google Scholar
• Pereira D, Peleteiro B, Araújo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage. 2011;19(11):1270–1285. doi:10.1016/j.joca.2011.08.009
   PubMed Web of Science ®Google Scholar
• Vos T, Allen C, Arora M. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545–1602. doi:10.1016/s0140-6736(16)31678-6
   PubMed Web of Science ®Google Scholar
• Prieto-Alhambra D, Judge A, Javaid MK, Cooper C, Diez-Perez A, Arden NK. Incidence and risk factors for clinically diagnosed knee, Hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann Rheum Dis. 2014;73(9):1659–1664. doi:10.1136/annrheumdis-2013-203355
   PubMed Web of Science ®Google Scholar
• Kye SY, Park K. Suicidal ideation and suicidal attempts among adults with chronic diseases: a cross-sectional study. Compr Psychiatry. 2017;73:160–167. doi:10.1016/j.comppsych.2016.12.001
   PubMed Web of Science ®Google Scholar
• Veronese N, Stubbs B, Solmi M, et al. Association between lower limb osteoarthritis and incidence of depressive symptoms: data from the osteoarthritis initiative. Age Ageing. 2017;46(3):470–476. doi:10.1093/ageing/afw216
   PubMed Web of Science ®Google Scholar
• Siviero P, Veronese N, Smith T, et al. Association between osteoarthritis and social isolation: data from the EPOSA study. J Am Geriatr Soc. 2020;68(1):87–95. doi:10.1111/jgs.16159
   PubMed Web of Science ®Google Scholar
• Xie F, Kovic B, Jin X, He X, Wang M, Silvestre C. Economic and humanistic burden of osteoarthritis: a systematic review of large sample studies. Pharmacoeconomics. 2016;34(11):1087–1100. doi:10.1007/s40273-016-0424-x
   PubMed Web of Science ®Google Scholar
• Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2021;17(1):47–57. doi:10.1038/s41584-020-00533-7
   PubMed Web of Science ®Google Scholar
• van der Esch M, Knoop J, Hunter DJ, et al. The association between reduced knee joint proprioception and medial meniscal abnormalities using MRI in knee osteoarthritis: results from the Amsterdam osteoarthritis cohort. Osteoarthritis Cartilage. 2013;21(5):676–681. doi:10.1016/j.joca.2013.02.002
   PubMed Web of Science ®Google Scholar
• Reid KF, Price LL, Harvey WF, et al. Muscle power is an independent determinant of pain and quality of life in knee osteoarthritis. Arthritis Rheumatol. 2015;67(12):3166–3173. doi:10.1002/art.39336
   PubMed Web of Science ®Google Scholar
• Muthuri SG, Zhang W, Maciewicz RA, Muir K, Doherty M. Beer and wine consumption and risk of knee or hip osteoarthritis: a case control study. Arthritis Res Ther. 2015;17(1):23. doi:10.1186/s13075-015-0534-4
   PubMed Web of Science ®Google Scholar
• Beaudart C, Lengelé L, Leclercq V, et al. Symptomatic efficacy of pharmacological treatments for knee osteoarthritis: a systematic review and a network meta-analysis with a 6-month time horizon. Drugs. 2020;80(18):1947–1959. doi:10.1007/s40265-020-01423-8
   PubMed Web of Science ®Google Scholar
• MacFarlane LA, Cook NR, Kim E, et al. The effects of vitamin D and marine omega-3 fatty acid supplementation on chronic knee pain in older US adults: results from a randomized trial. Arthritis Rheumatol. 2020;72(11):1836–1844. doi:10.1002/art.41416
   PubMed Web of Science ®Google Scholar
• Saberi Hosnijeh F, Zuiderwijk ME, Versteeg M, et al. Cam deformity and acetabular dysplasia as risk factors for hip osteoarthritis. Arthritis Rheumatol. 2017;69(1):86–93. doi:10.1002/art.39929
   PubMed Web of Science ®Google Scholar
• Wink AE, Gross KD, Brown CA, et al. Varus thrust during walking and the risk of incident and worsening medial tibiofemoral MRI lesions: the multicenter osteoarthritis study. Osteoarthritis Cartilage. 2017;25(6):839–845. doi:10.1016/j.joca.2017.01.005
   PubMed Web of Science ®Google Scholar
• Yin Y, Li X, Sha X, et al. Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway. Arterioscler Thromb Vasc Biol. 2015;35(4):804–816. doi:10.1161/atvbaha.115.305282
   PubMed Web of Science ®Google Scholar
• Tall AR, Westerterp M. Inflammasomes, neutrophil extracellular traps, and cholesterol. J Lipid Res. 2019;60(4):721–727. doi:10.1194/jlr.S091280
   PubMed Web of Science ®Google Scholar
• Pazár B, Ea HK, Narayan S, et al. Basic calcium phosphate crystals induce monocyte/macrophage IL-1β secretion through the NLRP3 inflammasome in vitro. J Immunol. 2011;186(4):2495–2502. doi:10.4049/jimmunol.1001284
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745–1759. doi:10.1016/s0140-6736(19)30417-9
   PubMed Web of Science ®Google Scholar
• Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(7):412–420. doi:10.1038/nrrheum.2016.65
   PubMed Web of Science ®Google Scholar
• Hsia AW, Emami AJ, Tarke FD, et al. Osteophytes and fracture calluses share developmental milestones and are diminished by unloading. J Orthop Res. 2018;36(2):699–710. doi:10.1002/jor.23779
   PubMed Web of Science ®Google Scholar
• Eyre D. Collagen of articular cartilage. Arthritis Res. 2002;4(1):30–35. doi:10.1186/ar380
   PubMedGoogle Scholar
• Guilak F, Nims RJ, Dicks A, Wu CL, Meulenbelt I. Osteoarthritis as a disease of the cartilage pericellular matrix. Matrix Biol. 2018;71–72:40–50. doi:10.1016/j.matbio.2018.05.008
   PubMed Web of Science ®Google Scholar
• Huang Z, Kraus VB. Does lipopolysaccharide-mediated inflammation have a role in OA? Nat Rev Rheumatol. 2016;12(2):123–129. doi:10.1038/nrrheum.2015.158
   PubMed Web of Science ®Google Scholar
• He Z, Nie P, Lu J, et al. Less mechanical loading attenuates osteoarthritis by reducing cartilage degeneration, subchondral bone remodelling, secondary inflammation, and activation of NLRP3 inflammasome. Bone Joint Res. 2020;9(10):731–741. doi:10.1302/2046-3758.910.Bjr-2019-0368.R2
   PubMed Web of Science ®Google Scholar
• Bai H, Yuan R, Zhang Z, et al. Intra-articular Injection of baicalein inhibits cartilage catabolism and NLRP3 inflammasome signaling in a posttraumatic OA model. Oxid Med Cell Longev. 2021;2021:6116890. doi:10.1155/2021/6116890
   PubMed Web of Science ®Google Scholar
• Wang M, Sampson ER, Jin H, et al. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Ther. 2013;15(1):R5. doi:10.1186/ar4133
   PubMed Web of Science ®Google Scholar
• Fosang AJ, Beier F. Emerging Frontiers in cartilage and chondrocyte biology. Best Pract Res Clin Rheumatol. 2011;25(6):751–766. doi:10.1016/j.berh.2011.11.010
   PubMed Web of Science ®Google Scholar
• Zhang L, Ma S, Su H, Cheng J. Isoliquiritigenin inhibits IL-1β-induced production of matrix metalloproteinase in articular chondrocytes. Mol Ther Methods Clin Dev. 2018;9:153–159. doi:10.1016/j.omtm.2018.02.006
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lin Z, Chen D, He Y. CY-09 attenuates the progression of osteoarthritis via inhibiting NLRP3 inflammasome-mediated pyroptosis. Biochem Biophys Res Commun. 2021;553:119–125. doi:10.1016/j.bbrc.2021.03.055
   PubMed Web of Science ®Google Scholar
• Burr DB. Anatomy and physiology of the mineralized tissues: role in the pathogenesis of osteoarthrosis. Osteoarthritis Cartilage. 2004;12(Suppl A):S20–30. doi:10.1016/j.joca.2003.09.016
   PubMedGoogle Scholar
• Sun FF, Hu PF, Xiong Y, Bao JP, Qian J, Wu LD. Tricetin protects rat chondrocytes against IL-1β-induced inflammation and apoptosis. Oxid Med Cell Longev. 2019;2019:4695381. doi:10.1155/2019/4695381
   PubMed Web of Science ®Google Scholar
• Thomson A, Hilkens CMU. Synovial macrophages in osteoarthritis: the key to understanding pathogenesis? Front Immunol. 2021;12:678757. doi:10.3389/fimmu.2021.678757
   PubMed Web of Science ®Google Scholar
• Ma Z, Wang Y, Piao T, Liu J. Echinocystic acid inhibits IL-1β-induced COX-2 and iNOS expression in human osteoarthritis chondrocytes. Inflammation. 2016;39(2):543–549. doi:10.1007/s10753-015-0278-y
   PubMed Web of Science ®Google Scholar
• Eitner A, Müller S, König C, et al. Inhibition of inducible nitric oxide synthase prevents IL-1β-induced mitochondrial dysfunction in human chondrocytes. Int J Mol Sci. 2021;22(5):2477. doi:10.3390/ijms22052477
   PubMed Web of Science ®Google Scholar
• Guerne PA, Carson DA, Lotz M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol. 1990;144(2):499–505.
   PubMed Web of Science ®Google Scholar
• Aigner T, McKenna L, Zien A, Fan Z, Gebhard PM, Zimmer R. Gene expression profiling of serum- and interleukin-1 beta-stimulated primary human adult articular chondrocytes–a molecular analysis based on chondrocytes isolated from one donor. Cytokine. 2005;31(3):227–240. doi:10.1016/j.cyto.2005.04.009
   PubMed Web of Science ®Google Scholar
• Pulsatelli L, Dolzani P, Piacentini A, et al. Chemokine production by human chondrocytes. J Rheumatol. 1999;26(9):1992–2001.
   PubMed Web of Science ®Google Scholar
• Wojdasiewicz P, Poniatowski ŁA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014;2014:561459. doi:10.1155/2014/561459
   PubMed Web of Science ®Google Scholar
• Olee T, Hashimoto S, Quach J, Lotz M. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol. 1999;162(2):1096–1100.
   PubMed Web of Science ®Google Scholar
• Futani H, Okayama A, Matsui K, et al. Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation. J Immunother. 2002;25(Suppl 1):S61–4. doi:10.1097/00002371-200203001-00009
   PubMed Web of Science ®Google Scholar
• Bao J, Chen Z, Xu L, Wu L, Xiong Y. Rapamycin protects chondrocytes against IL-18-induced apoptosis and ameliorates rat osteoarthritis. Aging. 2020;12(6):5152–5167. doi:10.18632/aging.102937
   PubMedGoogle Scholar
• Dai SM, Shan ZZ, Nishioka K, Yudoh K. Implication of interleukin 18 in production of matrix metalloproteinases in articular chondrocytes in arthritis: direct effect on chondrocytes may not be pivotal. Ann Rheum Dis. 2005;64(5):735–742. doi:10.1136/ard.2004.026088
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Barr AJ, Cicuttini FM, et al. Osteoarthritis. Nat Rev Dis Primers. 2016;2:16072. doi:10.1038/nrdp.2016.72
   PubMed Web of Science ®Google Scholar
• Mathiessen A, Conaghan PG. Synovitis in osteoarthritis: current understanding with therapeutic implications. Arthritis Res Ther. 2017;19(1):18. doi:10.1186/s13075-017-1229-9
   PubMed Web of Science ®Google Scholar
• Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51(2):249–257. doi:10.1016/j.bone.2012.02.012
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R, Terkeltaub R. Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol. 2015;11(1):35–44. doi:10.1038/nrrheum.2014.162
   PubMed Web of Science ®Google Scholar
• Ni Z, Kuang L, Chen H, et al. The exosome-like vesicles from osteoarthritic chondrocyte enhanced mature IL-1β production of macrophages and aggravated synovitis in osteoarthritis. Cell Death Dis. 2019;10(7):522. doi:10.1038/s41419-019-1739-2
   PubMed Web of Science ®Google Scholar
• Zhang L, Xing R, Huang Z, et al. Inhibition of synovial macrophage pyroptosis alleviates synovitis and fibrosis in knee osteoarthritis. Mediators Inflamm. 2019;2019:2165918. doi:10.1155/2019/2165918
   PubMed Web of Science ®Google Scholar
• Xiao Y, Ding L, Yin S, et al. Relationship between the pyroptosis of fibroblast‑like synoviocytes and HMGB1 secretion in knee osteoarthritis. Mol Med Rep. 2021;23(2). doi:10.3892/mmr.2020.11736
   Web of Science ®Google Scholar
• García-Arnandis I, Guillén MI, Gomar F, Pelletier JP, Martel-Pelletier J, Alcaraz MJ. High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes. Arthritis Res Ther. 2010;12(4):R165. doi:10.1186/ar3124
   PubMed Web of Science ®Google Scholar
• Kim HM, Kim YM. HMGB1: LPS delivery vehicle for caspase-11-mediated Pyroptosis. Immunity. 2018;49(4):582–584. doi:10.1016/j.immuni.2018.09.021
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang L, Huang Z, et al. Increased HIF-1α in knee osteoarthritis aggravate synovial fibrosis via fibroblast-like synoviocyte pyroptosis. Oxid Med Cell Longev. 2019;2019:6326517. doi:10.1155/2019/6326517
   PubMed Web of Science ®Google Scholar
• Shi J, Zhao W, Ying H, et al. Estradiol inhibits NLRP3 inflammasome in fibroblast-like synoviocytes activated by lipopolysaccharide and adenosine triphosphate. Int J Rheum Dis. 2018;21(11):2002–2010. doi:10.1111/1756-185x.13198
   PubMed Web of Science ®Google Scholar
• Hu J, Zhou J, Wu J, et al. Loganin ameliorates cartilage degeneration and osteoarthritis development in an osteoarthritis mouse model through inhibition of NF-κB activity and pyroptosis in chondrocytes. J Ethnopharmacol. 2020;247:112261. doi:10.1016/j.jep.2019.112261
   PubMed Web of Science ®Google Scholar
• Wang C, Gao Y, Zhang Z, et al. Ursolic acid protects chondrocytes, exhibits anti-inflammatory properties via regulation of the NF-κB/NLRP3 inflammasome pathway and ameliorates osteoarthritis. Biomed Pharmacother. 2020;130:110568. doi:10.1016/j.biopha.2020.110568
   PubMed Web of Science ®Google Scholar
• Stabler TV, Huang Z, Montell E, Vergés J, Kraus VB. Chondroitin sulphate inhibits NF-κB activity induced by interaction of pathogenic and damage associated molecules. Osteoarthritis Cartilage. 2017;25(1):166–174. doi:10.1016/j.joca.2016.08.012
   PubMed Web of Science ®Google Scholar
• Baek HS, Hong VS, Kim SH, Lee J, Kim S. KMU-1170, a novel multi-protein kinase inhibitor, suppresses inflammatory signal transduction in THP-1 cells and human osteoarthritic fibroblast-like synoviocytes by suppressing activation of NF-κB and NLRP3 inflammasome signaling pathway. Int J Mol Sci. 2021;22(3):1194. doi:10.3390/ijms22031194
   PubMed Web of Science ®Google Scholar
• Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, et al. Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: preclinical and clinical evidence in osteoarthritis and gout. Br J Pharmacol. 2022;179(2):270–286. doi:10.1111/bph.15707
   PubMed Web of Science ®Google Scholar
• Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677–687. doi:10.1038/nm.3893
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhong H, Wei J, et al. Inhibition of Nrf2/HO-1 signaling leads to increased activation of the NLRP3 inflammasome in osteoarthritis. Arthritis Res Ther. 2019;21(1):300. doi:10.1186/s13075-019-2085-6
   PubMed Web of Science ®Google Scholar
• Gao F, Zhang S. Loratadine alleviates advanced glycation end product-induced activation of NLRP3 inflammasome in human chondrocytes. Drug Des Devel Ther. 2020;14:2899–2908. doi:10.2147/dddt.S243512
   PubMed Web of Science ®Google Scholar
• Yan Z, Qi W, Zhan J, et al. Activating Nrf2 signalling alleviates osteoarthritis development by inhibiting inflammasome activation. J Cell Mol Med. 2020;24(22):13046–13057. doi:10.1111/jcmm.15905
   PubMed Web of Science ®Google Scholar
• Liao T, Ding L, Wu P, et al. Chrysin attenuates the NLRP3 inflammasome cascade to reduce synovitis and pain in KOA rats. Drug Des Devel Ther. 2020;14:3015–3027. doi:10.2147/dddt.S261216
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen M, Wang B, et al. Electroacupuncture alleviates osteoarthritis by suppressing NLRP3 inflammasome activation in guinea pigs. Evid Based Complement Alternat Med. 2020;2020:5476064. doi:10.1155/2020/5476064
   PubMed Web of Science ®Google Scholar
• Xia S, Hollingsworth L, Wu H. Mechanism and regulation of gasdermin-mediated cell death. Cold Spring Harb Perspect Biol. 2020;12(3):a036400. doi:10.1101/cshperspect.a036400
   PubMed Web of Science ®Google Scholar
• Rathkey JK, Zhao J, Liu Z, et al. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Sci Immunol. 2018;3(26). doi:10.1126/sciimmunol.aat2738
   PubMed Web of Science ®Google Scholar
• Hu JJ, Liu X, Xia S, et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020;21(7):736–745. doi:10.1038/s41590-020-0669-6
   PubMed Web of Science ®Google Scholar
• Sollberger G, Choidas A, Burn GL, et al. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci Immunol. 2018;3(26). doi:10.1126/sciimmunol.aar6689
   Web of Science ®Google Scholar
• Rühl S, Shkarina K, Demarco B, Heilig R, Santos JC, Broz P. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science. 2018;362(6417):956–960. doi:10.1126/science.aar7607
   PubMed Web of Science ®Google Scholar
• Xiao J, Wang C, Yao JC, et al. Gasdermin D mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice. PLoS Biol. 2018;16(11):e3000047. doi:10.1371/journal.pbio.3000047
   PubMed Web of Science ®Google Scholar
• Kanneganti A, Malireddi RKS, Saavedra PHV, et al. GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever. J Exp Med. 2018;215(6):1519–1529. doi:10.1084/jem.20172060
   PubMed Web of Science ®Google Scholar
• Rashidi M, Simpson DS, Hempel A, et al. The pyroptotic cell death effector gasdermin D Is activated by gout-associated uric acid crystals but is dispensable for cell death and il-1β release. J Immunol. 2019;203(3):736–748. doi:10.4049/jimmunol.1900228
   PubMed Web of Science ®Google Scholar
• Yang T, Sun K, Wang C, et al. Gasdermin D deficiency attenuates arthritis induced by traumatic injury but not autoantibody-assembled immune complexes. Arthritis Res Ther. 2021;23(1):286. doi:10.1186/s13075-021-02668-8
   PubMed Web of Science ®Google Scholar
• Ma C, Yang D, Wang B, et al. Gasdermin D in macrophages restrains colitis by controlling cGAS-mediated inflammation. Sci Adv. 2020;6(21):eaaz6717. doi:10.1126/sciadv.aaz6717
   PubMed Web of Science ®Google Scholar
• Bulek K, Zhao J, Liao Y, et al. Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis. J Clin Invest. 2020;130(8):4218–4234. doi:10.1172/jci138103
   PubMed Web of Science ®Google Scholar
• Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol. 2012;8(7):390–398. doi:10.1038/nrrheum.2012.80
   PubMed Web of Science ®Google Scholar
• Nasi S, Ea HK, So A, Busso N. Revisiting the Role Of Interleukin-1 Pathway In Osteoarthritis: Interleukin-1α and −1β, and NLRP3 inflammasome are not involved in the pathological features of the murine menisectomy model of osteoarthritis. Front Pharmacol. 2017;8:282. doi:10.3389/fphar.2017.00282
   PubMed Web of Science ®Google Scholar
• Vincent TL. IL-1 in osteoarthritis: time for a critical review of the literature. F1000Res. 2019;8:934. doi:10.12688/f1000research.18831.1
   Google Scholar
• Zhao LR, Xing RL, Wang PM, et al. NLRP1 and NLRP3 inflammasomes mediate LPS/ATP‑induced pyroptosis in knee osteoarthritis. Mol Med Rep. 2018;17(4):5463–5469. doi:10.3892/mmr.2018.8520
   PubMed Web of Science ®Google Scholar
• Ramesova A, Vesela B, Svandova E, Lesot H, Matalova E. Caspase-1 inhibition impacts the formation of chondrogenic nodules, and the expression of markers related to osteogenic differentiation and lipid metabolism. Int J Mol Sci. 2021;22(17):9576. doi:10.3390/ijms22179576
   PubMed Web of Science ®Google Scholar